FR2934119A1 - Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin - Google Patents
Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin Download PDFInfo
- Publication number
- FR2934119A1 FR2934119A1 FR0903329A FR0903329A FR2934119A1 FR 2934119 A1 FR2934119 A1 FR 2934119A1 FR 0903329 A FR0903329 A FR 0903329A FR 0903329 A FR0903329 A FR 0903329A FR 2934119 A1 FR2934119 A1 FR 2934119A1
- Authority
- FR
- France
- Prior art keywords
- selenium
- sodium chloride
- egg white
- water
- soy lecithin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 235000013305 food Nutrition 0.000 title claims abstract description 16
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 12
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 12
- 235000014103 egg white Nutrition 0.000 title claims abstract description 12
- 210000000969 egg white Anatomy 0.000 title claims abstract description 12
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 title claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 title claims abstract description 10
- 239000008347 soybean phospholipid Substances 0.000 title claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 229910001868 water Inorganic materials 0.000 title claims abstract description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 7
- 239000011669 selenium Substances 0.000 title claims abstract description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 6
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 title claims abstract description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 title claims abstract description 5
- 229960004488 linolenic acid Drugs 0.000 title claims abstract description 5
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 title claims abstract description 5
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 title claims abstract description 5
- 208000015181 infectious disease Diseases 0.000 title description 4
- 241000700584 Simplexvirus Species 0.000 title 1
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 claims abstract description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000011616 biotin Substances 0.000 claims abstract description 6
- 229960002685 biotin Drugs 0.000 claims abstract description 6
- 235000020958 biotin Nutrition 0.000 claims abstract description 6
- 239000011591 potassium Substances 0.000 claims abstract description 6
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims abstract description 5
- 239000006071 cream Substances 0.000 claims abstract description 5
- 239000010419 fine particle Substances 0.000 claims abstract description 4
- 239000003921 oil Substances 0.000 claims abstract description 4
- 235000019198 oils Nutrition 0.000 claims abstract description 4
- 229910052809 inorganic oxide Inorganic materials 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 3
- 230000010534 mechanism of action Effects 0.000 abstract description 2
- 239000008240 homogeneous mixture Substances 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 2
- 230000001195 anabolic effect Effects 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 239000012873 virucide Substances 0.000 abstract 1
- 241000700605 Viruses Species 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 239000003797 essential amino acid Substances 0.000 description 9
- 235000020776 essential amino acid Nutrition 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 241001515965 unidentified phage Species 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 230000001320 lysogenic effect Effects 0.000 description 5
- 206010037844 rash Diseases 0.000 description 5
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 235000020845 low-calorie diet Nutrition 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 230000007420 reactivation Effects 0.000 description 4
- 230000009089 cytolysis Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000001688 Herpes Genitalis Diseases 0.000 description 2
- 241000194035 Lactococcus lactis Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 210000000234 capsid Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 201000004946 genital herpes Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000028744 lysogeny Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000005026 persistent vegetative state Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/01—Other fatty acid esters, e.g. phosphatides
- A23D7/011—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
DESCRIPTION .:' COMPOSITION ALIMENTAIRE EQUILIBREE En ACIDES AMINES ESSENTIELS, DESTINEE A SUPPRIMER LES REACTIVATIONS DE L'HERPES GENITAL CHEZ L'HOMME.. DESCRIPTION: BALANCED FOOD COMPOSITION IN ESSENTIAL AMINO ACIDS, TO DELETE THE REACTIVATIONS OF GENITAL HERPES IN MAN.
La présente demande concerne l'invention d'une composition alimentaire spéciale propre à empêcher la réactivation cu virus HSV2 chez les sujets ayant une alimentation hypocalorique et déséquilibrée en acides aminés essentiels et se refusant à la modifier. The present application relates to the invention of a special food composition capable of preventing the reactivation of HSV2 virus in subjects having a low calorie diet and imbalanced in essential amino acids and refusing to modify it.
Cette invention appartient au domaine des produits alimentaires normaux. TECHNIQUES ANTERIEURES Des recherches effectuées dans les diverses bases de données n'ont pas permis de trouver des compositions alimentaires semblables à celle du demandeur. Ce dernier a déposé une demande sur un sujet proche en décembre 2008 et enregistrée sous le numéro 08 06 116. LES TRAVAUX DU DEMANDEUR Le demandeur a découvert comment par une diététique correctrice on peut supprimer les réactivations du virus HSV2 chez des sujets souffrant d'éruptions herpétiques récidivantes. This invention belongs to the field of normal food products. PRIOR TECHNIQUES Searches carried out in the various databases did not make it possible to find food compositions similar to that of the applicant. The latter filed a request on a related subject in December 2008 and registered under the number 08 06 116. THE WORK OF THE APPLICANT The applicant has discovered how a corrective dietetic can suppress the reactivation of the HSV2 virus in subjects suffering from eruptions recurrent herpetic.
LE DEMANDEUR PRECISE TOUT DE SUITE QUE SA DEMANDE NE CONCERNE PAS DU TOUT SA DECOUVERTE QUI EST EXPOSEE ICI UNIQUEMENT POUR FAIRE COMPRENDRE L'ACTION DE SA COMPOSITION ALIMENTAIRE. IL PRECISE QU'UNE PARTIE DE SES TRAVAUX ONT ETE EXPOSES AVEC SA DEMANDE 08 06 116. IL VA EXPOSER Cl DESSOUS LA SUITE DE SES RECHERCHES. THE APPLICANT SPECIFIES IMMEDIATELY THAT HIS APPLICATION IS NOT CONCERNED AT ALL HIS DISCOVERY WHICH IS EXHIBITED HERE ONLY TO UNDERSTAND THE ACTION OF ITS FOOD COMPOSITION. IT STATES THAT A PART OF ITS WORK HAVE BEEN PRESENT WITH ITS REQUEST 08 06 116. IT WILL EXHIBIT BELOW THE FOLLOWING OF ITS RESEARCH.
Le demandeur a publié dans le N° 3N du 23 octobre 2008 de la revue Glucides Lucide dont le depot légal a été fait le 23/10/2008 à la Bibliothèque Nationale de France (Revue éditée par Olivier Roujansky, 1 allée des Bécassines 40200 Mimizan (France) un article expliquant que chez une patiente ayant souffert d'herpes recidivant pendant 57 ans, les réactivations du virus étaient dues à ce qu'elle suivait en permanence un régime Basses Calories et surtout que lors de son petit déjeuner elle ne mangeait que 80 grammes de pain et 10 grammes de beurre : ceci n'apportant que 5 grammes de protéines de très mauvaise qualite et 360 calories ce qui était très insuffisant pour couvrir ses besoins entre 6h30 et 12h30 ; la conséquence étant que la synthèse de protéines immunitaires était altérée, d'où les récidives. Le demandeur avait amené la patiente à manger lors de son petit déjeuner 40 grammes de viande de poulet ce qui avait diminué considérablement la fréquence et la sévérité des récidives. 11 en a conclu qu'on pourrait améliorer l'immunité de nombreux sujets chez lesquels elle est altérée si on complétait leur alimentation dans certains crénaux horaires avec les acides aminés essentiels déficitaires, soit en les fournissant à l'état pur, soit en apportant des aliments ou des produits les contenant (par 15 exemple de la viande ou de la chair de poisson). ICI COMMENCE LA PARTIE INFORMATIVE REDIGEE EN JUIN 2009 Tout d'abord il est précisé que la revue Glucides Lucide a paru en novembre et décembre 2008 (N°4N-18/11/08, N°5N-19111/08). 20 Après le dépôt de sa peécédente demande le demandeur s'est Interrogé à propos du mecanisme d'action de la supplémentation en acides aminés essentiels. Il a lu des articles de revues relatifs aux virus ayant des cycles de latences-réactivations. Articles principaux : 1/Génétic Régulatory Méchanisms in the 25 25 Synthésis of Protéins - François Jacob et Jacques Monod - J.MoI.BioI. 1961-3. 318-356. 2/ Effects of Diverse Environemental Conditions on oméga LC3 Prophage Stability in Lactococcus lactis. Merete Lunde et autres. Applied and Environemental Microbiology February 2005 p721-727- vol 71 N°2. (Note : F Jacob et 30 J Monod reçurent le Prix Nobel pour leurs travaux). Al Dans cet article N°1 est étudié le bactériophage qui parasite et détruit la bactérie Colibacille. Ce bactériophage est un DNA virus composé d'un fragment de DNA (un virion) et d'une enveloppe protéique appelée capside. Le virion entre dans la 35 bactérie sans la capside et peut prendre 2 états. 1/ Dans l'état dit "végétative state" il fait synthétiser par les ribosomes de la bactérie des métabolites nécessaires à sa dupli- cation. Ensuite il se multiplie très intensément en créant une centaine -ou plus- de bactériophages complets (encapsidés) qui s'agglomèrent en particules infectantes. Ce processus se termine par la lyse de la bactérie qui libère ces particules. 2/ Dans l'état dit "Phage state" le fragment de DNA s'associe avec le chromosome de la bactérie qui acquièrt la propriété spéciale de ne plus pouvoir synthétiser les métabolites nécessaires à la duplication. La bactérie est dite "lysogénic". Le fragment de DNA reste dans la bactérie même quand elle se divise. Cet état de latence peut durer indéfiniment. Mais il peut cesser sous diverses influences : par exemple par irradiation ultraviolette ou par modification des conditions de culture de la bactérie (par exemple abaissement de la température - voir page 338 de l'article). La réactivation du virus redémarre la phase "végétative state" qui se termine par la lyse de la bactérie et la dissémination dans le milieu des particules infectantes. F Jacob et J Monod ont identifié le mécanisme de la lysogénie : le fragment de DNA -dit Prophage- qui s'associe au chromosome, induit la synthèse d'un "répresseur" qui inhibe la synthèse des métabolites par les ribosomes ce qui rend impossible la duplication du virus. Ainsi le virus connait 2 destins : -soit végétatif avec lyse de la bactérie et dissémination dans le milieu de culture -soit lysogénic, ou s'incorporant au génome de la bactérie il va survivre aussi longtemps que son hotesse et que ses descendantes. B/ Dans l'article N°2, les auteurs ont étudié un bactériophage de la bactérie Lactococcus lactis. Ils ont mis en lumière le fait que l'induction du "végétative state" zst provoqué par des modifications du milieu de culture. Ainsi, un milieu pauvre accroît la fréquence de survenue des "végétative states" : Ces résultats concordent avec ceux de l'article 1. Les propriétés de ces bacteriophages sont très semblables à celles du virus HSV2 pour certaines caracteristiques : DNA virus pouvant être actif ou en état de latence. Mais il y a une différence entre eux : les bactériophages se multiplient dans des bactéries croissant sur un milieu de culture simple, le virus HSV2, par contre, se développe chez des animaux ayant des besoins nutritionnels très élevés et complexes. Le demandeur observe que les virus sont des structures ne pouvant avoir des activités de synthèse. Ils ne peuvent induire leur multiplication que par l'intermédiaire d'une cellule vivante dans laquelle ils se sont introduits. Ceci entraine la conséquence que le degré de fourniture des nutriments aux cellules hôtes conditionnera la possibilité ou non, pour les virus de se multiplier ou de se mettre en état de latence. Ceci a également pour autre conséquence que chaque virus aura une demande specifique d'hébergement. Chez les animaux, la fourniture suffisante ou non en tel ou tel nutriment pourra enclencher une maladie virale ou la mettre en sommeil. Le demandeur observe maintenant la propagation de l'herpes. The applicant published in the No. 3N of October 23, 2008 the magazine Glucides Lucide whose legal deposit was made on October 23, 2008 at the National Library of France (Review edited by Olivier Roujansky, 1 alley Bécassines 40200 Mimizan (France) an article explaining that in a patient who had suffered from recurrent herpes for 57 years, the reactivations of the virus were due to the fact that she constantly followed a low calorie diet and especially that during her breakfast she ate only 80 grams of bread and 10 grams of butter: this bringing only 5 grams of protein of very poor quality and 360 calories which was very insufficient to cover its needs between 6:30 and 12:30, the consequence being that the synthesis of immune proteins was the applicant had brought the patient to eat at breakfast 40 grams of chicken meat which had significantly decreased the frequency of This has led to the conclusion that the immunity of many subjects in whom it is impaired could be improved by supplementing their diet in certain time periods with the essential amino acids that are deficient, or by providing them to the patient. pure state, either by providing food or products containing them (for example meat or fish meat). HERE BEGINS THE COMPUTER PART SET FORTH IN JUNE 2009 First of all it is stated that the magazine Glucides Lucide was published in November and December 2008 (N ° 4N-18/11/08, N ° 5N-19111/08). After the filing of his previous application, the Applicant asked about the mechanism of action of supplementation with essential amino acids. He has read journal articles on viruses with latency-reactivation cycles. Main articles: 1 / Regulatory Genetics Mechanisms in the 25 25 Synthesis of Proteins - François Jacob and Jacques Monod - J.MoI.BioI. 1961-3. 318-356. 2 / Effects of Diverse Environmental Conditions on Omega LC3 Propagation Stability in Lactococcus lactis. Merete Lunde and others. Applied and Environmental Microbiology February 2005 p721-727- vol 71 No. 2. (Note: F Jacob and 30 J Monod received the Nobel Prize for their work). Al In this article N ° 1 is studied the bacteriophage which parasitizes and destroys the bacterium Colibacille. This bacteriophage is a DNA virus composed of a fragment of DNA (a virion) and a protein envelope called capsid. The virion enters the bacterium without the capsid and can take 2 states. 1 / In the so-called "vegetative state" it makes synthesize by the ribosomes of the bacterium of the metabolites necessary for its duplication. Then it multiplies very intensely by creating a hundred or more complete bacteriophages (encapsidated) which agglomerate into infectious particles. This process ends with the lysis of the bacteria that releases these particles. 2 / In the "Phage state" state, the DNA fragment associates with the chromosome of the bacterium, which acquires the special property of not being able to synthesize the metabolites necessary for duplication. The bacterium is called "lysogenic". The DNA fragment remains in the bacterium even when it divides. This latency state can last indefinitely. But it may cease under various influences: for example by ultraviolet irradiation or by changing the culture conditions of the bacteria (eg lowering of temperature - see page 338 of the article). The reactivation of the virus restarts the "vegetative state" phase, which ends with the lysis of the bacterium and the dissemination in the environment of the infecting particles. F Jacob and J Monod have identified the mechanism of lysogeny: the fragment of DNA -dit Prophage- which associates with the chromosome, induces the synthesis of a "repressor" which inhibits the synthesis of metabolites by ribosomes which makes it impossible duplication of the virus. Thus the virus knows 2 destinies: -if vegetative lysis of the bacterium and dissemination in the culture medium -so lysogénic, or incorporating the genome of the bacterium it will survive as long as his hostess and her descendants. B / In the article N ° 2, the authors studied a bacteriophage of the bacterium Lactococcus lactis. They have highlighted the fact that the induction of the "vegetative state" is caused by changes in the culture medium. Thus, a poor environment increases the frequency of occurrence of "vegetative states": These results are consistent with those of Article 1. The properties of these bacteriophages are very similar to those of the HSV2 virus for some characteristics: DNA virus can be active or in latency state. But there is a difference between them: bacteriophages multiply in bacteria growing on a simple culture medium, the HSV2 virus, on the other hand, develops in animals with very high and complex nutritional needs. The applicant observes that viruses are structures that can not have synthetic activities. They can only induce their multiplication by means of a living cell into which they have introduced themselves. This leads to the consequence that the degree of supply of nutrients to the host cells will condition the possibility or not, for viruses to multiply or to put in a state of latency. This also has the consequence that each virus will have a specific request for hosting. In animals, the sufficient or insufficient supply of one or other nutrient may trigger a viral disease or put it to sleep. The applicant is now observing the spread of the herpes.
Elle a lieu quand la peau des régions péri-génitales d'un être humain entre en contact avec des vésicules ouvertes d'une éruption herpétique. Les fragments viraux pénètrent dans les cellules et s'y multiplient en provoquant une éruption cutanée qui passe par les stades érythémateuxb puis vésiculeux puis de vésicules ouvertes d'où sort une sérosité chargée en virus. Dans la norme, l'herpes guérit spontanémsnt en 8 à 12 jours. Le malade "guéri" reste porteur du virus qui est devenu inactif et est localisé dans les ganglions latéro-vertébraux où se trouvent les neurones sensitifs innervant la zone infectée. On dit que le virus est dans un "sanctuaire" où les médicaments antiviraux ne peuvent l'atteindre. Là, le virus reste passif, parfois pendant des années, parfois pendant la vie entière du sujet. Dans d'autres cas, le virus se réactive et une éruption nouvelle a lieu qui suit son cours comme lors de la primo-infection. On voit que l'état lysogénic des bactériophages et celui 5 d'inactivité du HSV2 ont un air de famille. Toutes ces données étant prises en compte, le demandeur émet la théorie suivante. On doit considérer d'une part la certitude des données relatives aux virus, d'autre part la réalité de la suppression des 10 récurrences herpétiques par la correction d'un déficit en acides aminés essentiels lors d'une fenêtre temporelle d'une durée de plusieurs heures chez un patient ayant une alimentation hypocalorique. II y a lieu de penser que lors de la multiplication du virus HSV2 15 au cours de la primo-infection ou d'une récurrence, il se produit des mutations créant des mutants "lysogénics" ayant la propriété de faire synthétiser dans les cellules hotes un répresseur inhibant la synthèse des protéines indispensables à la multiplication du virus. Alors commence la phase de latence 20 qui durera aussi longtemps que les nutriments nécessaires à la synthèse du répresseur seront fournis à la cellule hôte. Mais si la cellule hôte est sous alimentée en l'un où plusieurs de ces nutriments, la synthèse du répresseur diminue ou s'annule et le "végétative state" redémarre avec son éruption et 25 l'apparition par mutations de nouveaux "lysogénics" virus générant un nouvel état de latence. Dans le cas de la malade, on a identifié les acides aminés essentiels (en particulier la lysine et la thréonine) comme nutriments en cause chez une patiente alimentée seulement 30 avec du pain (lors d'une "fenêtre"). II reste à identifier tous les autres facteurs qui peuvent déclencher des récurrences en cas de régime déficitaire en calories et en certains acides aminés essentiels. It occurs when the skin of the peri-genital regions of a human being comes into contact with open vesicles of a herpetic rash. The viral fragments penetrate into the cells and multiply by causing a rash that passes through the erythematous stagesb then vesicular and open vesicles from which a serum loaded with virus. Normally, herpes cures spontaneously in 8 to 12 days. The "cured" patient remains a carrier of the virus that has become inactive and is located in the latero-vertebral ganglia where the sensory neurons innervating the infected zone are located. It is said that the virus is in a "sanctuary" where antiviral drugs can not reach it. There, the virus remains passive, sometimes for years, sometimes during the entire life of the subject. In other cases, the virus reactivates and a new eruption takes place that follows its course as during the primary infection. It can be seen that the lysogenic state of bacteriophages and that of inactivity of HSV2 have a family resemblance. All these data being taken into account, the applicant emits the following theory. On the one hand, one must consider the certainty of the data relating to the viruses, on the other hand the reality of the suppression of the herpetic recurrences by the correction of an essential amino acid deficit during a time window of a duration of several hours in a patient with a low calorie diet. It is to be expected that during the multiplication of the HSV2 virus during primary infection or recurrence, mutations are created creating "lysogenic" mutants having the property of making synthesize in the host cells a repressor inhibiting the synthesis of proteins essential for the multiplication of the virus. Then begins the lag phase which will last as long as the nutrients required for repressor synthesis will be provided to the host cell. But if the host cell is under-fed to one or more of these nutrients, the repressor synthesis decreases or vanishes and the "vegetative state" restarts with its eruption and the appearance by mutations of new "lysogenics" viruses. generating a new latency state. In the case of the patient, essential amino acids (particularly lysine and threonine) were identified as the nutrients involved in a patient fed only with bread (at a "window"). It remains to identify all the other factors that can trigger recurrences in case of diet deficient in calories and certain essential amino acids.
En définitive le demandeur énonce ceci , l'herpes génitaj est du à la multiplication du virus HSV2 dans des cellules. Lors de cette multiplication apparaissent des mutants induisant la synthèse dans la cellule hôte d'un répresseur empêchant la cellule de synthétiser des métabolites indispensables à la multiplication du virus. Le virus devient latent. Si à un moment, le sujet reçoit un régime hypocalorique avec un apport insuffisant en nutriments nécessaires à la multiplication du répresseur, le système devient instable. Sous l'influence d'un facteur déclen- chant (par exemple une anémie, une fièvre, un traumatisme, un stress, etc), il pourra entrer en phase de multiplication active. La phase de multiplication cessera quand des mutants "lysogénics" seront assez nombreux. Le nouvel état de latence et de stabilité se maintiendra aussi longtemps que les cellules hôtes seront approvisionnées avec les nutriments dont elles ont besoin pour fabriquer des répresseurs. Note : La malade dont il est question plus haut, a été supplémentée en acides aminés essentiels à partir du début de février 2008. En 2008 elle a fait 3 rechutes d'herpes. En 2009 (6 mois au 29 juin) elle en a fait 1. En 2003, elle avait fait 12 rechutes. Entre 2002 et 2007 c'est à dire en 6 années elle avait fait 45 rechutes. Cet excellent résultat qui se maintient depuis 17 mois (au 30 juin 2009) amène le demandeur a déposer cette nouvelle 25 demande de brevet. Ultimately the applicant states this, the genital herpes is due to the multiplication of the HSV2 virus in cells. During this multiplication appear mutants inducing synthesis in the host cell of a repressor preventing the cell from synthesizing metabolites essential for the multiplication of the virus. The virus becomes latent. If at a given time, the subject receives a low-calorie diet with insufficient nutrient supply necessary for the multiplication of the repressor, the system becomes unstable. Under the influence of a triggering factor (for example, anemia, fever, trauma, stress, etc.), he may enter the active multiplication phase. The multiplication phase will stop when "lysogenic" mutants are numerous. The new state of latency and stability will continue as long as the host cells are supplied with the nutrients they need to make repressors. Note: The patient referred to above, was supplemented with essential amino acids from the beginning of February 2008. In 2008 she made 3 herpes relapses. In 2009 (6 months to June 29) she made 1. In 2003, she made 12 relapses. Between 2002 and 2007 that is to say in 6 years she had made 45 relapses. This excellent result, which has been maintained for 17 months (as of June 30, 2009), brings the applicant to file this new patent application.
ICI PREND FIN LA PARTIE INFORMATIVE POUR LAQUELLE IL N'EST PAS DEMANDE DE PROTECTION. HERE IS ENDING THE INFORMATIVE PART FOR WHICH IT IS NOT REQUEST FOR PROTECTION.
ICI COMMENCE LA SECONDE PARTIE DE LA DEMANDE DE BREVET DE L'INVENTION. HERE STARTS THE SECOND PART OF THE PATENT APPLICATION FOR THE INVENTION.
30 Se fondant sur ce qui vient d'être exposé, le demandeur a inventé la composition suivante. Le composant primordial en est le blanc d'oeuf dont les protéines présentent un équilibre parfait en acides aminés. (Le poussin sera fabriqué avec elles). Ce blanc sera cuit à 95 35 degrés de façon à inactiver l'avidine et il sera enrichi en biotine. Lui seront ajoutés : du tofu, de la lécithine de soja, une huile végétale riche en acide jinolénique, du chlorure de sodium, du potassium, du sélénium, de l'eau, de la biotine. Le demandeur, au cours de sa carrère de médecin, a vu que de nombreuses personnes suivaient un régime franchement pathogène et refusaient de le corriger. Il a donc résolu d'inventer une composition alimentaire qui serait basée sur sa découverte et serait facilement acceptée par eux. Ceci étant, le demandeur décrit la composition d'une unité complémentaire de base servant à complémenter un repas déséquilibré en acides aminés essentiels et en 'énergie (du type végétalien) pour un adulte homme de poids moyen. COMPOSANTS ET FABRICATION D'UNE DOSE UNITAIRE On the basis of what has just been stated, the Applicant has invented the following composition. The essential component is the egg white whose proteins have a perfect balance of amino acids. (The chick will be made with them). This white will be cooked at 95 degrees so as to inactivate avidin and it will be enriched in biotin. It will be added: tofu, soy lecithin, a vegetable oil rich in jinolenic acid, sodium chloride, potassium, selenium, water, biotin. The plaintiff, during his career as a doctor, saw that many people were following a truly pathogenic diet and refused to correct it. He therefore resolved to invent a food composition that would be based on his discovery and would be easily accepted by them. That being so, the applicant describes the composition of a basic supplemental unit for supplementing an unbalanced meal with essential amino acids and energy (vegan type) for a middle-aged adult male. COMPONENTS AND MANUFACTURE OF A UNIT DOSE
Cette dose unitaire contient : 80 à 100 grammes de blanc d'oeuf et d'autres composants préparés comme ci-après. This unit dose contains: 80 to 100 grams of egg white and other components prepared as below.
Composition alimentaire caractérisée en ce qu'elle est composée, pour une dose unitaire de 80 à 100 grammes, de 70 grammes de blanc d'oeuf, d'huile végétale contenant 1 gramme d'acide oméga 3 linolenique natf et non surajouté, de 1 gramme de chlorure de sodium, de 0,4 à 1 gramme de potassium sous forme d'un sel d'un acide faible de qualité alimentaire, de 2 grammes d'eau, de 50 micogrammes de sélénium sous forme de dioxyde sélénium, de 2 grammes de lécithine de soja ; cette composition est caractérisée encore en ce que le blanc d'oeuf est cuit et coagulé à sec à 90 degrés puis broyé en fines particules et caractérisée encore en ce que le broyat obtenu est additionné de l'huile, de la lécithine de soja et des autres composants, et de 200 microgrammes de biotine, le melange étant mixé très longuement jusqu'à obtention d'une crême homogène, cette composition est caractérisée encore en ce que le chlorure de sodium, le sel de potassium, et le dioxyde de sélénium sont dissous dans l'eau, et est caractérisé encore en ce que la solution de sels et oxydes minéraux est additionnée à la crême, l'ensemble étant brassé longuement jusqu'à obtention d'un gel homogène. Note : les personnes comprenant mal l'article 1 auront intérêt à lire le livre de F.Jacob, La Statue Intérieure où il dépeint ses recherches avec Monod et leurs découvertes. Les explications sont plus accessibles pour les non spécialistes. Voir surtout les pages : 380-381, 396, 406-411, 417-423, 426-430 (édition format livre de poche). On notera que "l'immunité" vis à vis du virus latent ne dépend pas du système immunitaire mais du statut lysogénic ou non du virion. MEILLEURE REALISATION DE L'INVENTION _La meilleure composition unitaire est préparée avec 90 grammes de blanc d'oeuf et le reste comme ci dessus mais avec spécialement : potassium 1 gramme, Food composition characterized in that it is composed, for a unit dose of 80 to 100 grams, of 70 grams of egg white, of vegetable oil containing 1 gram of omega 3 linolenic acid natf and not superadjusted, of 1 gram of sodium chloride, 0.4 to 1 gram of potassium in the form of a salt of a weak acid of food grade, 2 grams of water, 50 micograms of selenium in the form of selenium dioxide, 2 grams of soy lecithin; this composition is further characterized in that the egg white is cooked and coagulated to 90 degrees dry and then ground to fine particles and further characterized in that the ground material obtained is supplemented with oil, soy lecithin and other components, and 200 micrograms of biotin, the mixture being mixed very long until a homogeneous cream is obtained, this composition is further characterized in that the sodium chloride, the potassium salt, and the selenium dioxide are dissolved in water, and is further characterized in that the solution of salts and inorganic oxides is added to the cream, the whole being stirred for a long time until a homogeneous gel is obtained. Note: people with a bad understanding of Article 1 will be interested in reading F. Jacob's book, The Inner Statue, where he describes his research with Monod and their discoveries. The explanations are more accessible for non-specialists. See especially pages: 380-381, 396, 406-411, 417-423, 426-430 (paperback edition). It should be noted that "immunity" with respect to the latent virus does not depend on the immune system but on the lysogenetic status or not of the virion. BEST IMPLEMENTATION OF THE INVENTION The best unitary composition is prepared with 90 grams of egg white and the remainder as above but especially with: potassium 1 gram,
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0903329A FR2934119A1 (en) | 2009-07-06 | 2009-07-06 | Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0903329A FR2934119A1 (en) | 2009-07-06 | 2009-07-06 | Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2934119A1 true FR2934119A1 (en) | 2010-01-29 |
Family
ID=41571812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0903329A Pending FR2934119A1 (en) | 2009-07-06 | 2009-07-06 | Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2934119A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2923358A1 (en) * | 2008-11-03 | 2009-05-15 | Olivier Roujansky | Food composition, useful for strengthening immunity to fight against chronic viral diseases, comprises meat/fish, vegetable oil containing alpha-linolenic acid, sodium chloride, potassium, water, and selenium |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001093910A2 (en) * | 2000-06-05 | 2001-12-13 | Vis-Vitalis Lizenz- Und Handels Ag | Method for increasing the antioxidative potential of selenium-containing aqueous solutions |
| WO2002087599A1 (en) * | 2001-04-30 | 2002-11-07 | Ramaekers D V M Joseph C | Compositions for treating animal diseases and syndromes |
| US20060115555A1 (en) * | 2004-12-01 | 2006-06-01 | Foulger Sidney W | Nutritional supplements containing xanthone extracts |
| US20060280840A1 (en) * | 2005-05-24 | 2006-12-14 | Robertson Marion G | Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system |
| US20080268095A1 (en) * | 2007-04-20 | 2008-10-30 | Edmund Clemens Herzog | Dietary Supplement for the Compensation of Nutritional Deficiency |
| FR2923358A1 (en) * | 2008-11-03 | 2009-05-15 | Olivier Roujansky | Food composition, useful for strengthening immunity to fight against chronic viral diseases, comprises meat/fish, vegetable oil containing alpha-linolenic acid, sodium chloride, potassium, water, and selenium |
-
2009
- 2009-07-06 FR FR0903329A patent/FR2934119A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001093910A2 (en) * | 2000-06-05 | 2001-12-13 | Vis-Vitalis Lizenz- Und Handels Ag | Method for increasing the antioxidative potential of selenium-containing aqueous solutions |
| WO2002087599A1 (en) * | 2001-04-30 | 2002-11-07 | Ramaekers D V M Joseph C | Compositions for treating animal diseases and syndromes |
| US20060115555A1 (en) * | 2004-12-01 | 2006-06-01 | Foulger Sidney W | Nutritional supplements containing xanthone extracts |
| US20060280840A1 (en) * | 2005-05-24 | 2006-12-14 | Robertson Marion G | Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system |
| US20080268095A1 (en) * | 2007-04-20 | 2008-10-30 | Edmund Clemens Herzog | Dietary Supplement for the Compensation of Nutritional Deficiency |
| FR2923358A1 (en) * | 2008-11-03 | 2009-05-15 | Olivier Roujansky | Food composition, useful for strengthening immunity to fight against chronic viral diseases, comprises meat/fish, vegetable oil containing alpha-linolenic acid, sodium chloride, potassium, water, and selenium |
Non-Patent Citations (3)
| Title |
|---|
| GRIFFITH R S ET AL: "A MULTICENTERED STUDY OF LYSINE THERAPY IN HERPES SIMPLEX INFECTION", DERMATOLOGICA, S.KARGER, BASEL, CH, vol. 156, no. 5, 1 January 1978 (1978-01-01), pages 257 - 267, XP008069436, ISSN: 0011-9075 * |
| MILLER C S ET AL: "Use of lysine in treating recurrent oral herpes simplex infections", GENERAL DENTISTRY, ACADEMY OF GENERAL DENTISTRY, CHICAGO, US, vol. 32, no. 6, 1 November 1984 (1984-11-01), pages 490 - 493, XP009103691, ISSN: 0363-6771 * |
| VAN EECKHOUT, M., ET AL.: "Effect of diet on herpes simplex virus, type 1, infection in mice", NUTRITION RESEARCH, vol. 14, no. 4, 30 April 1994 (1994-04-30), pages 545 - 552, XP002571910, DOI: 10.1016/S0271-5317(05)80218-0 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2923358A1 (en) * | 2008-11-03 | 2009-05-15 | Olivier Roujansky | Food composition, useful for strengthening immunity to fight against chronic viral diseases, comprises meat/fish, vegetable oil containing alpha-linolenic acid, sodium chloride, potassium, water, and selenium |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Simpore et al. | Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola | |
| Hildes et al. | The changing picture of neoplastic disease in the western and central Canadian Arctic (1950-1980) | |
| Hieb et al. | Heme requirement for reproduction of a free-living nematode | |
| RU2011133891A (en) | METHOD FOR TREATING ASTHMA (OPTIONS) AND METHOD FOR REDUCING THE RISK OF INFECTIONS DEVELOPMENT BY β-HYDROXY-β-METHYLBUTYRATE | |
| Jones | Shiitake: the healing mushroom | |
| Wan-Mohtar et al. | Fermented foods as alternative functional foods during post-pandemic in Asia | |
| NL1022153C2 (en) | Cholesterol lowering preparation, food supplement and food and methods for the preparation thereof. | |
| MORGAN | The treatment of alcoholic hepatitis. | |
| FR2934119A1 (en) | Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin | |
| KR100842053B1 (en) | The composition comprising extract of Cinnamomum cassia bark for improving normal flora and enhancing immune response | |
| Cunha et al. | Effects of prolonged oral nutritional support in malnourished cirrhotic patients: results of a pilot study | |
| TW200817020A (en) | Lipid-metabolism-ameliorating agent | |
| JPH05170659A (en) | Composition for lowering blood alcohol concentration | |
| JPH0912466A (en) | Lipid absorption inhibitor / excretion enhancer and high fat food | |
| JP2004161730A (en) | New antihypertensive substance | |
| FI113613B (en) | Food compositions and processes for their preparation | |
| Maniruzzaman et al. | Role of diet, exercise, and aging process on the human immune system | |
| JP2840851B2 (en) | Fish immunopotentiator and fish culture feed | |
| JP3506466B2 (en) | Capsaicin glycoside, dihydrocapsaicin glycoside, method for producing them, and food containing them | |
| Reich et al. | Moderate fats in infectious hepatitis: A new concept based on recent advances | |
| FR2923358A1 (en) | Food composition, useful for strengthening immunity to fight against chronic viral diseases, comprises meat/fish, vegetable oil containing alpha-linolenic acid, sodium chloride, potassium, water, and selenium | |
| KR20190025519A (en) | Fish sauce containing increased tryptophan content | |
| Fallon | Nasty, brutish and short? | |
| JP2003325110A (en) | Feed for hen and egg obtained by giving the same | |
| Miller | The Anti-anxiety Diet: A Whole Body Programme to Stop Racing Thoughts, Banish Worry and Live Panic-free |